Ronald Blue Trust, Inc. Compugen LTD Transaction History
Ronald Blue Trust, Inc.
- $7.21 Billion
- Q2 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Compugen LTD stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 3,629 shares of CGEN stock, worth $6,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,629Holding current value
$6,350% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CGEN
# of Institutions
75Shares Held
13.4MCall Options Held
191KPut Options Held
135K-
Silverarc Capital Management, LLC1.5MShares$2.63 Million0.72% of portfolio
-
Taylor Frigon Capital Management LLC1.31MShares$2.3 Million1.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.26 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.9 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.79 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $152M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...